Inclusion Body Myositis (IBM)
Also known as: Myositis, Inclusion Body / Inclusion Body Myositis / Inclusion body myositis [IBM] / Inclusion body myositis (disorder)
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00005 | Etanercept | 0 | Completed | 1 |
| DB00108 | Natalizumab | 1 | Unknown Status | 1 |
| DB06819 | Phenylbutyric acid | 1 | Completed | 1 |
| DB01132 | Pioglitazone | 1 | Completed | 1 |
| DB18281 | Ulviprubart | 1 | Active Not Recruiting | 1 |
| DB00087 | Alemtuzumab | 2 | Completed | 1 |
| DB05025 | Arimoclomol | 2 | Completed | 1 |
| DB00026 | Anakinra | 2 / 3 | Completed | 1 |
| DB05025 | Arimoclomol | 2 / 3 | Completed | 1 |
| DB00877 | Sirolimus | 2 / 3 | Completed | 1 |
| DB18281 | Ulviprubart | 2 / 3 | Active Not Recruiting | 1 |
| DB05025 | Arimoclomol | 3 | Terminated | 1 |
| DB00877 | Sirolimus | 3 | Recruiting | 1 |